Protein profile

KP13_00581

6-phosphofructokinase

Genome: KpKP13

Gene: AHE47056.1 pfkA Structure source: AlphaFold + ColabFold UniProt A0A0H3GGY4
Amino acids 320
Annotations 14
Features 38
PDB binders 6
Druggability 0.066

Overview

Basic information about this protein and its source genome.

Accession
KP13_00581
Gene
AHE47056.1 pfkA
Status
annotated
Amino acids
320
Structure source
AlphaFold + ColabFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
57.778
Human E-value
6.1e-09
Gut microbiome off-target
hit
Essential (DEG)
Y
DEG identity (%)
72.188
DEG E-value
8.46e-173
Localization
Cytoplasmic
ColabFold pLDDT
96.17

Selected Druggability evidence

AlphaFold / UniProt model

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.066
Structure A0A0H3GGY4
Pocket Pocket 7
P2Rank 0.544
Structure A0A0H3GGY4
Pocket Pocket 1
ColabFold model
FPocket 0.547 · Pocket 6
P2Rank 0.652 · Pocket 1
Core conservation Conserved core gene
Roary core
CoreCruncher core
Gut microbiome 1016 / 4744 genomes with a hit
Normalized 0.214

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 13 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

13
  • GO:0008443 Catalysis of the transfer of a phosphate group, usually from ATP, to a phosphofructose substrate molecule.
  • GO:0006002 The chemical reactions and pathways involving fructose 6-phosphate, also known as F6P. The D-enantiomer is an important intermediate in glycolysis, gluconeogenesis, and fructose metabolism.
  • GO:0005524 Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
  • GO:0003872 Catalysis of the reaction: ATP + D-fructose-6-phosphate = ADP + D-fructose 1,6-bisphosphate.
  • GO:0006096 The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP and the reduction of NAD(P) to NAD(P)H. Glycolysis begins with the metabolism of a carbohydrate to generate products that can enter the pathway and ends with the production of pyruvate. Pyruvate may be converted to acetyl-coenzyme A, ethanol, lactate, or other small molecules.
  • GO:0005945 A protein complex that possesses 6-phosphofructokinase activity; homodimeric, homooctameric, and allosteric homotetrameric forms are known.
  • GO:0016208 Binding to AMP, adenosine monophosphate.
  • GO:0070095 Binding to fructose 6-phosphate.
  • GO:0042802 Binding to an identical protein or proteins.
  • GO:0046872 Binding to a metal ion.
  • GO:0048029 Binding to a monosaccharide. Monosaccharides are the simplest carbohydrates; they are polyhydroxy aldehydes H[CH(OH)]nC(=O)H or polyhydroxy ketones H[CHOH]nC(=O)[CHOH]mH with three or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides.
  • GO:0061621 The glycolytic process that begins with the conversion of glucose to glucose-6-phosphate by glucokinase activity. Glycolytic processes are the chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP.
  • GO:0030388 The chemical reactions and pathways involving fructose 1,6-bisphosphate, also known as FBP. The D enantiomer is a metabolic intermediate in glycolysis and gluconeogenesis.

Sequence Features

Domain/signature hits from InterPro and related databases.

38 records
Show feature table
Start End DB Term Name
3 320 CDD cd00763 Bacterial_PFK
3 320 InterPro IPR012828 ATP-dependent 6-phosphofructokinase, prokaryotic
3 311 SUPERFAMILY SSF53784 Phosphofructokinase
3 311 InterPro IPR035966 Phosphofructokinase superfamily
244 262 ProSitePatterns PS00433 Phosphofructokinase signature.
244 262 InterPro IPR015912 Phosphofructokinase, conserved site
4 276 Pfam PF00365 Phosphofructokinase
4 276 InterPro IPR000023 Phosphofructokinase domain
2 320 Hamap MF_00339 ATP-dependent 6-phosphofructokinase [pfkA].
2 320 InterPro IPR012828 ATP-dependent 6-phosphofructokinase, prokaryotic
4 301 NCBIfam TIGR02482 6-phosphofructokinase
4 301 InterPro IPR012828 ATP-dependent 6-phosphofructokinase, prokaryotic
3 305 PANTHER PTHR13697 PHOSPHOFRUCTOKINASE
143 252 Gene3D G3DSA:3.40.50.460 Phosphofructokinase domain
143 252 InterPro IPR035966 Phosphofructokinase superfamily
4 168 FunFam G3DSA:3.40.50.450:FF:000001 ATP-dependent 6-phosphofructokinase
4 280 Gene3D G3DSA:3.40.50.450 -
1 320 PIRSF PIRSF000532 ATP_PFK_prok
1 320 InterPro IPR012003 ATP-dependent 6-phosphofructokinase, prokaryotic-type
7 26 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
7 26 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
32 45 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
32 45 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
139 157 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
139 157 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
213 225 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
213 225 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
177 194 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
177 194 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
240 262 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
240 262 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
159 175 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
159 175 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
94 110 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
94 110 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
121 138 PRINTS PR00476 ATP-dependent phosphofructokinase family signature
121 138 InterPro IPR022953 ATP-dependent 6-phosphofructokinase
143 252 FunFam G3DSA:3.40.50.460:FF:000002 ATP-dependent 6-phosphofructokinase

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 2

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold AF_A0A0H3GGY4
AlphaFold full sequence Viewing
ColabFold KP13_00581
ColabFold full sequence Loaded
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (P2RANK)

Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).

P2RANK Sticks Spheres Surfaces Score Probability Labels Zoom Positions
1 6.49 0.328
2 1.53 0.023

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

59 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
ACP Q01813 505.2 Da LogP -1.52 TPSA 269.9 3 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
ANP Q2FXM8 506.2 Da LogP -2.06 TPSA 281.9 3 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
F6P P99165 260.1 Da LogP -3.10 TPSA 156.9 1 viol. ✓ Clean C([C@@H]1[C@H]([C@@H]([C@](O1)(CO)O)O)O)OP(=O)(…
FLC P99165 189.1 Da LogP -5.25 TPSA 140.6 ✓ Ro5 ✓ Clean C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
PEP P00512 168.0 Da LogP -0.31 TPSA 104.1 ✓ Ro5 ✓ Clean C=C(C(=O)O)OP(=O)(O)O
PGA P00512 156.0 Da LogP -0.82 TPSA 104.1 ✓ Ro5 ✓ Clean C(C(=O)O)OP(=O)(O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.